b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">\n        <PMID Version="1">29126649</PMID>\n        <DateCompleted>\n            <Year>2018</Year>\n            <Month>10</Month>\n            <Day>03</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>03</Month>\n            <Day>18</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1879-0887</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>126</Volume>\n                    <Issue>3</Issue>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>Mar</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</Title>\n                <ISOAbbreviation>Radiother Oncol</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Is dose de-escalation possible in sarcoma patients treated with enlarged limb sparing resection?</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>493-498</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S0167-8140(17)32677-4</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.radonc.2017.10.026</ELocationID>\n            <Abstract>\n                <AbstractText Label="PURPOSE">To evaluate the impact of dose de-escalation in a large series of resected limbs soft tissue sarcomas (STS).</AbstractText>\n                <AbstractText Label="METHODS">Data were retrospectively analysed from 414 consecutive patients treated for limb STS by enlarged surgery and radiotherapy at Gustave Roussy from 05/1993 to 05/2012. Radiotherapy (RT) dose level was decided by the multidisciplinary staff and depended upon the quality of surgery and margins size.</AbstractText>\n                <AbstractText Label="RESULTS">RT was delivered prior (13%) or after (87%) surgery. Seven patients (2%) had pre- and a postoperative RT boost. Median delivered RT dose was 50\xe2\x80\xafGy (36-70\xe2\x80\xafGy), and 33% received \xe2\x89\xa555\xe2\x80\xafGy. At a median follow-up of 6.8\xe2\x80\xafyears, the 5-year actuarial local relapse (LR) rate was 7% (95% CI: 4.4-10%). The median time to the first LR was 2.7\xe2\x80\xafyears (range: 0.6-11.2\xe2\x80\xafyears). The LR was most often located within the irradiated field (26/32; 81%), where the median total applied dose was 56\xe2\x80\xafGy (range, 40-60\xe2\x80\xafGy). The 5-year LR rates were 4%, and 15% in patients receiving &lt;55\xe2\x80\xafGy, and in those who had \xe2\x89\xa555\xe2\x80\xafGy (p\xe2\x80\xaf&lt;\xe2\x80\xaf0.001), respectively. In the multivariate analysis, dose \xe2\x89\xa555\xe2\x80\xafGy (HR [hazard ratio]: 2.9; p\xe2\x80\xaf=\xe2\x80\xaf0.02), certain histological subtypes (HR: 7.8; p\xe2\x80\xaf&lt;\xe2\x80\xaf0.001), and minimal surgical margins &lt;1\xe2\x80\xafmm (HR: 2.9; p\xe2\x80\xaf=\xe2\x80\xaf0.02) were associated to higher LR rates. In the subgroup of patients with &quot;positive&quot; margins &lt;1\xe2\x80\xafmm (n\xe2\x80\xaf=\xe2\x80\xaf102), these histological subtypes (HR: 4.4; p\xe2\x80\xaf=\xe2\x80\xaf0.03), and inadequate initial surgery justifying re-excision (HR: 3; p\xe2\x80\xaf=\xe2\x80\xaf0.048) predicted for an increased LR, whereas dose of irradiation did not (p\xe2\x80\xaf=\xe2\x80\xaf0.2). Patients who had late complications (n\xe2\x80\xaf=\xe2\x80\xaf64; 15%) received higher doses of irradiation as compared with other patients (median: 55\xe2\x80\xafGy vs. 50\xe2\x80\xafGy, respectively; p\xe2\x80\xaf&lt;\xe2\x80\xaf0.001).</AbstractText>\n                <AbstractText Label="CONCLUSION">In this retrospective analysis of patients having enlarged surgery and RT, histological subtype is the strongest predictor of LR, whereas dose de-escalation did not lead to worse outcomes. A dose of 50\xe2\x80\xafGy may be recommended in case of planned enlarged surgery with R0 margins.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2017 Elsevier B.V. All rights reserved.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Levy</LastName>\n                    <ForeName>Antonin</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Radiation Oncology, Gustave Roussy, Universit\xc3\xa9 Paris-Saclay, Villejuif, France; INSERM U1030, Molecular Radiotherapy, Gustave Roussy, Universit\xc3\xa9 Paris-Saclay, Villejuif, France; Univ Paris Sud, Universit\xc3\xa9 Paris-Saclay, Le Kremlin-Bic\xc3\xaatre, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Bonvalot</LastName>\n                    <ForeName>Sylvie</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Surgery, Institut Curie, PSL Research University, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Bellefqih</LastName>\n                    <ForeName>Sara</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Radiation Oncology, Gustave Roussy, Universit\xc3\xa9 Paris-Saclay, Villejuif, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Terrier</LastName>\n                    <ForeName>Philippe</ForeName>\n                    <Initials>P</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pathology, Gustave-Roussy, Universit\xc3\xa9 Paris Saclay, Villejuif, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Le Cesne</LastName>\n                    <ForeName>Axel</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medical Oncology, Gustave-Roussy, Universit\xc3\xa9 Paris Saclay, Villejuif, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Le P\xc3\xa9choux</LastName>\n                    <ForeName>C\xc3\xa9cile</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Radiation Oncology, Gustave Roussy, Universit\xc3\xa9 Paris-Saclay, Villejuif, France. Electronic address: cecile.lepechoux@gustaveroussy.fr.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2017</Year>\n                <Month>11</Month>\n                <Day>07</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Ireland</Country>\n            <MedlineTA>Radiother Oncol</MedlineTA>\n            <NlmUniqueID>8407192</NlmUniqueID>\n            <ISSNLinking>0167-8140</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004307" MajorTopicYN="N">Dose-Response Relationship, Radiation</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005121" MajorTopicYN="N">Extremities</DescriptorName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n                <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D023821" MajorTopicYN="N">Limb Salvage</DescriptorName>\n                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D020360" MajorTopicYN="N">Neoadjuvant Therapy</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011879" MajorTopicYN="N">Radiotherapy Dosage</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D018714" MajorTopicYN="N">Radiotherapy, Adjuvant</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012509" MajorTopicYN="N">Sarcoma</DescriptorName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n                <QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>\n                <QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">Enlarged surgery</Keyword>\n            <Keyword MajorTopicYN="Y">Limbs</Keyword>\n            <Keyword MajorTopicYN="Y">Radiotherapy</Keyword>\n            <Keyword MajorTopicYN="Y">Soft tissue sarcoma</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2017</Year>\n                <Month>03</Month>\n                <Day>26</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2017</Year>\n                <Month>09</Month>\n                <Day>04</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2017</Year>\n                <Month>10</Month>\n                <Day>20</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2017</Year>\n                <Month>11</Month>\n                <Day>12</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>4</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2017</Year>\n                <Month>11</Month>\n                <Day>12</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29126649</ArticleId>\n            <ArticleId IdType="pii">S0167-8140(17)32677-4</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.radonc.2017.10.026</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'